CTSB and breast cancer: Indeed, analysis of cathepsin B/Z double-deficient mice in the context of the MMTV-PyMT breast cancer model revealed a strongly reduced tumor and lung metastatic burden, while a single cathepsin Z deficiency had no clear effect on the overall tumor phenotype (Sevenich et al., 2010).